CLB70 cells, derived from a dog with chronic lymphocytic leukemia, showed higher resistance to treatment overall, requiring stronger signals such as BrCl-F-mediated Bcl-2/Bcl-XL downregulation to undergo apoptosis. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.